Quick Takeaways
- Nantahala Capital Management, LLC filed SCHEDULE 13G/A for Lyra Therapeutics, Inc. Common Stock, $0.001 par value per share (LYRA).
- Disclosed ownership: 1.1%.
- Date of event: 30 Sep 2024.
Nantahala Capital Management, LLC - 30 Sep 2024 SCHEDULE 13G/A Report for Lyra Therapeutics, Inc. Common Stock, $0.001 par value per share (LYRA)
- Filing Manager
- Nantahala Capital Management, LLC
- Reporting Manager
- Nantahala Capital Management, LLC
- Symbol
- LYRA
- Shares outstanding
- 66,161,515 shares
- Disclosed Ownership
- 702,106 shares
- Ownership
- 1.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2024, 16:53:53 UTC
- Date of event
- 30 Sep 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Nantahala Capital Management, LLC disclosed 1.1% ownership in Lyra Therapeutics, Inc. Common Stock, $0.001 par value per share (LYRA) on 30 Sep 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2024, 16:53.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 1.1% | 702,106 | 0 | 702,106 | /s/ Taki Vasilakis | Taki Vasilakis / Chief Compliance Officer | |
| Wilmot B. Harkey | 1.1% | 702,106 | 0 | 702,106 | /s/ Wilmot B. Harkey | Wilmot B. Harkey | |
| Daniel Mack | 1.1% | 702,106 | 0 | 702,106 | /s/ Daniel Mack | Daniel Mack |